Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention
1 other identifier
interventional
42
1 country
1
Brief Summary
The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to complete questionnaires and participate in 4 sessions with research chaplains.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
January 29, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2019
CompletedFebruary 13, 2020
February 1, 2020
9 months
January 29, 2019
February 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Rate of enrollment
number of eligible patients that are consented and enrolled in the trial
from recruitment to enrollment (i.e. up to 30 days)
Attendance Rate
proportion of participants who attend all four intervention sessions
4 weeks
Mean Satisfaction Score
satisfaction score among participants on the satisfaction survey
4 weeks
Functional assessment of chronic illness therapy-Spiritual Well-being Scale Scores
Total score at baseline will be compared to score at to the score at 1 week, 6 weeks, and 3 months
baseline, 1-2 weeks after session 4, 6 weeks, 3 months
Secondary Outcomes (9)
Percentage of completed baseline surveys
baseline
Percentage of completed follow up surveys
baseline, 1-2 weeks after session 4, 6 weeks, 3 months
McGrill Quality of Life Questionnaire score
baseline, 1-2 weeks after session 4, 6 weeks, 3 months
Caregiver Quality of Life Index-Cancer Questionnaire score
baseline, 1 week, 6 weeks, 3 months
Caregiver Quality of Life Index-Cancer Questionnaire score
baseline, 1-2 weeks after session 4, 6 weeks, 3 months
- +4 more secondary outcomes
Study Arms (1)
Spiritual Care Assessment and Intervention
EXPERIMENTALInterventions
4 sessions completed with an IU Health chaplain using a framework of questions called the Spiritual Care Assessment And Intervention tool. The weekly sessions will focus on one of the 4 areas of spiritual experience (meaning and purpose, relationships, transcendence and peace, self-worth and identity)
Eligibility Criteria
You may qualify if:
- Patient is at least 18 years of age.
- Patient is at least 2 weeks post-diagnosis of an incurable and advanced stage (IV) lung, colorectal, GI neuroendocrine and Hepatobiliary, testicular and esophageal solid malignancy and receiving cancer care at IU Simon Cancer Center.
- Patient is willing and able to consent, has a reliable phone and willing to participate in 4 sessions of 30 (+/- 5) minutes per session.
- Patient has a family member or eligible friend considered to be a caregiver and interested in participating in the study.
- Patient has adequate English fluency for completion of data collection.
- Family Caregiver (FCG) is at least 18 years of age.
- Family Caregiver (FCG) has been invited to participate in the trial with a patient who meets eligibility criteria above.
- Family Caregiver (FCG) is willing and able to consent and to participate in 4 sessions of 30 (+/- 5) minutes per session
- Family Caregiver (FCG) has adequate English fluency for completion of data collection.
You may not qualify if:
- Patient makes 3 or more errors on a validated 6-item cognitive screener (Appendix A) or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
- Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).
- Family Caregiver (FCG) exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Indiana University Healthcollaborator
Study Sites (1)
Indiana University Melvin & Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexia Torke, MD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine and Associate Division Chief of General Internal Medicine and Geriatrics
Study Record Dates
First Submitted
January 29, 2019
First Posted
January 30, 2019
Study Start
December 10, 2018
Primary Completion
August 28, 2019
Study Completion
August 28, 2019
Last Updated
February 13, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share